| Financial Year |
March 31 2023 |
| Monetary Funds |
165,624,801.51 |
| Held-for-trading Financial Assets |
518,162,128.48 |
| Notes Receivable |
-- |
| Accounts Receivable |
-- |
| Advances to Suppliers |
38,295,945.06 |
| Other Receivables |
62,037.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
203,676,026.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,291,589.06 |
| Total Current Assets |
961,112,528.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
856,867,962.87 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,525,035.82 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,641,650.03 |
| Deferred Income Tax Assets |
885,670.73 |
| Other Non-Current Assets |
1,348,872,122.87 |
| Sub-Total of Non-Current Assets |
2,271,617,842.53 |
| Total Assets |
3,232,730,370.61 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
157,055,000.00 |
| Accounts Payable |
36,283,908.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,847,259.60 |
| Taxes Payable |
5,267,786.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,838.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,553,121.67 |
| Other Current Liabilities |
977,911.85 |
| Sub-Total of Current Liabilities |
211,550,225.76 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,488,434.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,232,293.02 |
| Total Liabilities |
221,782,518.78 |
| Paid-In Capital(Or Share Stock) |
193,712,353.00 |
| Capital Surplus |
2,570,396,735.21 |
| Surplus Reserve |
88,649,672.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
157,055,675.81 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,010,947,851.83 |
| Owner's Equity（Stockholder's Equity） |
3,010,947,851.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,232,730,370.61 |
